Signal transduction in trophoblast invasion

Chemical Immunology and Allergy

Volumn 88, Issue , 2005, Pages 181-199

  Fitzgerald, Justine S ^a   Busch, Susann ^a   Wengenmayer, Tobias ^a   Foerster, Katharina ^a   De La Motte, Torben ^a   Poehlmann, Tobias G ^a   Markert, Udo R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; JANUS KINASE; LEPTIN; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; SOMATOMEDIN BINDING PROTEIN; STAT3 PROTEIN;

BINDING SITE; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHORIOCARCINOMA; ENDOMETRIUM; ENZYME ACTIVATION; HUMAN; NONHUMAN; PHENOTYPE; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TROPHOBLAST;

ANIMALS; CELL MOVEMENT; HUMANS; NEOPLASMS; PROTEIN-TYROSINE KINASES; RAS PROTEINS; SIGNAL TRANSDUCTION; TROPHOBLASTS;

EID: 30744477219     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000087834     Document Type: Review

References (99)

1. Murray MJ, Lessey BA: Embryo implantation and tumor metastasis: Common pathways of invasion and angiogenesis. Semin Reprod Endocrinol 1999;17:275-290.
2. Koldovsky U: Combined aspects of pregnancy and tumor immunology. Zentralbl Gynäkol 1999;121:185-189.
3. Kliman HJ: The placenta revealed. Am J Pathol 1993;143:332-336.
4. Bischof P, Meisser A, Campana A: Paracrine and autocrine regulators of trophoblast invasion - a review. Placenta 2000;21(suppl A):S55-S60.
5. Randall S, Buckley CH, Fox H: Placentation in the fallopian tube. Int J Gynecol Pathol 1987;6:132-139.
6. Poehlmann T, Bashar S, Markert UR, Caniggia I, Han V, Croy BA, Tayade C: There are many approaches to the culture of human trophoblast but few that facilitate study of complex interactions between fetal and maternal tissues. Placenta 2004;25:357-358.
7. Ovid: Metamorphoses. 8 a.d.: vv: XIV. 382.
8. Krebs DL, Hilton DJ: SOCS: Physiological suppressors of cytokine signaling. J Cell Sci 2000;113:2813-2819.
9. Ihle JN: Janus kinases in cytokine signalling. Philos Trans R Soc Lond B Biol Sci 1996;351:159-166.
10. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE Jr: Stat3 as an oncogene. Cell 1999;98:295-303.
11. Bowman T, Garcia R, Turkson J, Jove R: STATs in oncogenesis. Oncogene 2000;19:2474-2488.
12. Akira S: Functional roles of STAT family proteins: Lessons from knockout mice. Stem Cells 1999;17:138-146.
13. Duncan SA, Zhong Z, Wen Z, Darnell JE Jr: STAT signaling is active during early mammalian development. Dev Dyn 1997;208:190-198.
14. Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S: Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 1997;94:3801-3804.
15. Ortmann RA, Cheng T, Visconti R, Frucht DM, O'Shea JJ: Janus kinases and signal transducers and activators of transcription: Their roles in cytokine signaling, development and immunoregulation. Arthritis Res 2000;2:16-32.
16. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T: Interleukin-6 tri-ggers the association of its receptor with a possible signal transducer, gp130. Cell 1989;58:573-581.
17. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T: Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990;63:1149-1157.
18. Corvinus FM, Fitzgerald JS, Friedrich K, Markert UR: Evidence for a correlation between trophoblast invasiveness and STAT3 activity. Am J Reprod Immunol 2003;50:316-321.
19. Fitzgerald JS, Tsareva SA, Berod L, Poehlmann TG, Meissner A, Carovinus FM, Wiederanders B, Pfitzner E, Markert UR, Friedrich K: Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells. Int J Biochem Cell Biol, in press.
20. Bischof P, Meisser A, Campana A: Biochemistry and molecular biology of trophoblast invasion. Ann NY Acad Sci 2001;943:157-162.
21. Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL: Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992;267:4583-4591.
22. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH, Fisher SJ: 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991;113:437-449.
23. Kamens J, Paskind M, Hugunin M, Talanian RV Allen H, Banach D, Bump N, Hackett M, Johnston CG, Li P, et al: Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases. J Biol Chem 1995;270:15250-15256.
24. Poehlmann TG, Fitzgerald JS, Meissner A, Wengenmayer T, Schleussner E, Friedrich K, Markert UR: Trophoblast invasion: Tuning through LIF, signalling via Stat3. Placenta 2005;26:S37-S41.
25. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P: Molecular Biology of the Cell. New York, Garland Science, 2002, pp 871-880.
26. Kyriakis JM, Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001;81:807-869.
27. Kennedy NJ, Davis RJ: Role of JNK in tumor development. Cell Cycle 2003;2:199-201.
28. Zhang W, Liu HT: MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 2002;12:9-18.
29. Sagata N: What does Mos do in oocytes and somatic cells? Bioessays 1997;19:13-21.
30. Mudgett JS, Ding J, Guh-Siesel L, Chartrain NA, Yang L, Gopal S, Shen MM: Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci USA 2000;97:10454-10459.
31. Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, Perez L, Klein R, Nebreda AR: Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 2000;6:109-116.
32. Tamura K, Sudo T, Senftleben U, Dadak AM, Johnson R, Karin M: Requirement for p38alpha in erythropoietin expression: A role for stress kinases in erythropoiesis. Cell 2000;102:221-231.
33. Yan L, Carr J, Ashby PR, Murry-Tait V, Thompson C, Arthur JS: Knockout of ERK5 causes multiple defects in placental and embryonic development. BMC Dev Biol 2003;3:11.
34. Desai J, Holt-Shore V, Torry RJ, Caudle MR, Torry DS: Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol Reprod 1999;60:887-892.
35. Li HY, Chang SP, Yuan CC, Chao HT, Ng HT, Sung YJ: Induction of p38 mitogen-activated protein kinase-mediated apoptosis is involved in outgrowth of trophoblast cells on endometrial epithelial cells in a model of human trophoblast-endometrial interactions. Biol Reprod 2003;69:1515-1524.
36. Yoshino O, Osuga Y, Hirota Y, Koga K, Hirata T, Yano T, Ayabe T, Tsutsumi O, Taketani Y: Endometrial stromal cells undergoing decidualization down-regulate their properties to produce proinflammatory cytokines in response to interleukin-1 beta via reduced p38 mitogen-activated protein kinase phosphorylation. J Clin Endocrinol Metab 2003;88:2236-2241.
37. Kita N, Mitsushita J, Ohira S, Takagi Y, Ashida T, Kanai M, Nikaido T, Konishi I: Expression and activation of MAP kinases, ERK1/2, in the human villous trophoblasts. Placenta 2003;24:164-172.
38. Ichikawa N, Zhai YL, Shiozawa T, Toki T, Noguchi H, Nikaido T, Fujii S: Immunohistochemical analysis of cell cycle regulatory gene products in normal trophoblast and placental site trophoblastic tumor. Int J Gynecol Pathol 1998;17:235-240.
39. Cauzac M, Czuba D, Girard J, Hauguel-de Mouzon S: Transduction of leptin growth signals in placental cells is independent of JAK-STAT activation. Placenta 2003;24:378-384.
40. Ernst M, Inglese M, Waring P, Campbell IK, Bao S, Clay FJ, Alexander WS, Wicks IP, Tarlinton DM, Novak U, Heath JK, Dunn AR: Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med 2001;194:189-203.
41. Ahmed ST, Mayer A, Ji JD, Ivashkiv LB: Inhibition of IL-6 signaling by a p38-dependent pathway occurs in the absence of new protein synthesis. J Leukoc Biol 2002;72:154-162.
42. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F: Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003;374:1-20.
43. Boulton TG, Zhong Z, Wen Z, Darnell JE Jr, Stahl N, Yancopoulos GD: STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc Natl Acad Sci USA 1995;92:6915-6919.
44. Decker T, Kovarik P: Serine phosphorylation of STATs. Oncogene 2000;19:2628-2637.
45. Jain N, Zhang T, Fong SL, Lim CP, Cao X: Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). Oncogene 1998;17:3157-3167.
46. Schuringa JJ, Wierenga AT, Kruijer W, Vellenga E: Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6. Blood 2000;95:3765-3770.
47. Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Matsumoto K, Nakamura T, Kaneda Y, Horiuchi M, Ogihara T: Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Hypertension 2001;37:581-586.
48. Cacalano NA, Sanden D, Johnston JA: Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat Cell Biol 2001;3:460-465.
49. Stoiber D, Stockinger S, Steinlein P, Kovarik J, Decker T: Listeria monocytogenes modulates macrophage cytokine responses through STAT serine phosphorylation and the induction of suppressor of cytokine signaling 3. J Immunol 2001;166:466-472.
50. De Souza D, Fabri LJ, Nash A, Hilton DJ, Nicola NA, Baca M: SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities. Biochemistry 2002;41:9229-9236.
51. Magrangeas F, Boisteau O, Denis S, Jacques Y, Minvielle S: Negative regulation of onconstatin M signaling by suppressor of cytokine signaling (SOCS-3). Eur Cytokine Netw 2001;12:309-315.
52. Proud CG: The multifaceted role of mTOR in cellular stress responses. DNA Repair (Amst) 2004;3:927-934.
53. Wiederrecht GJ, Sabers CJ, Brunn GJ, Martin MM, Dumont FJ, Abraham RT: Mechanism of action of rapamycin: New insights into the regulation of G1-phase progression in eukaryotic cells. Prog Cell Cycle Res 1995;1:53-71.
54. GangloffYG, Mueller M, Dann SG, Svoboda P, Sticker M, Spetz JF, Um SH, Brown EJ, Cereghini S, Thomas G, Kozma SC: Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol 2004;24:9508-9516.
55. Murakami M, Ichisaka T, Maeda M, Oshiro N, Hara K, Edenhofer F, Kiyama H, Yonezawa K, Yamanaka S: mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 2004;24:6710-6718.
56. Qiu Q, Yang M, Tsang BK, Gruslin A: Both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signalling are required in epidermal growth factor-induced human trophoblast migration. Mol Hum Reprod 2004;10:677-684.
57. Yokogami K, Wakisaka S, Avruch J, Reeves SA: Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr Biol 2000;10:47-50.
58. Bass KE, Morrish D, Roth I, Bhardwaj D, Taylor R, Zhou Y, Fisher SJ: Human cytotrophoblast invasion is up-regulated by epidermal growth factor: Evidence that paracrine factors modify this process. Dev Biol 1994;164:550-561.
59. Li RH, Zhuang LZ: The effects of growth factors on human normal placental cytotrophoblast cell proliferation. Hum Reprod 1997;12:830-834.
60. Morrish DW, Dakour J, Li H: Functional regulation of human trophoblast differentiation. J Reprod Immunol 1998;39:179-195.
61. Hamilton GS, Lysiak JJ, Watson AJ, Lala PK: Effects of colony stimulating factor-1 on human extravillous trophoblast growth and invasion. J Endocrinol 1998;159:69-77.
62. Athanassiades A, Hamilton GS, Lala PK: Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol Reprod 1998;59:643-654.
63. Crocker IP, Strachan BK, Lash GE, Cooper S, Warren AY, Baker PN: Vascular endothelial growth factor but not placental growth factor promotes trophoblast syncytialization in vitro. J Soc Gynecol Investig 2001;8:341-346.
64. Zhang J, Cao YJ, Li FY, Li J, Yao LB, Duan EK: Effects of fibronectin, VEGF and angiostatin on the expression of MMPs through different signaling pathways in the JEG-3 cells. Am J Reprod Immunol 2003;50:273-285.
65. Athanassiades A, Lala PK: Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta 1998;19:465-473.
66. Chakraborty C, Gleeson LM, McKinnon T, Lala PK: Regulation of human trophoblast migration and invasiveness. Can J Physiol Pharmacol 2002;80:116-124.
67. Lala PK, Hamilton GS: Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue. Placenta 1996;17:545-555.
68. McKinnon T, Chakraborty C, Gleeson LM, Chidiac P, Lala PK: Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab 2001;86:3665-3674.
69. Graham CH, Lysiak JJ, McCrae KR, Lala PK: Localization of transforming growth factor-beta at the human fetal-maternal interface: Role in trophoblast growth and differentiation. Biol Reprod 1992;46:561-572.
70. Xu G, Chakraborty C, Lala PK: Expression of TGF-beta signaling genes in the normal, premalignant, and malignant human trophoblast: Loss of smad3 in choriocarcinoma cells. Biochem Biophys Res Commun 2001;287:47-55.
71. Xu G, Guimond MJ, Chakraborty C, Lala PK: Control of proliferation, migration, and invasiveness of human extravillous trophoblast by decorin, a decidual product. Biol Reprod 2002;67:681-689.
72. Schonherr E, Levkau B, Schaefer L, Kresse H, Walsh K: Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1). J Biol Chem 2001;276:40687-40692.
73. Aplin JD, Lacey H, Haigh T, Jones CJ, Chen CP, Westwood M: Growth factor-extracellular matrix synergy in the control of trophoblast invasion. Biochem Soc Trans 2000;28:199-202.
74. Lacey H, Haigh T, Westwood M, Aplin JD: Mesenchymally-derived insulin-like growth factor 1 provides a paracrine stimulus for trophoblast migration. BMC Dev Biol 2002;2:5.
75. Maruo T, Murata K, Matsuo H, Samoto T, Mochizuki M: Insulin-like growth factor-I as a local regulator of proliferation and differentiated function of the human trophoblast in early pregnancy. Early Pregnancy 1995;1:54-61.
76. Loke YW, King A, Gardner L, Carter NP: Evidence for the expression of granulocyte-macrophage colony-stimulating factor receptors by human first trimester extravillous trophoblast and its response to this cytokine. J Reprod Immunol 1992;22:33-45.
77. Imakawa K, Carlson KD, McGuire WJ, Christenson RK, Taylor A: Enhancement of ovine trophoblast interferon by granulocyte macrophage-colony stimulating factor: Possible involvement of protein kinase C. J Mol Endocrinol 1997;19:121-130.
78. Kauma SW, Bae-Jump V, Walsli SW: Hepatocyte growth factor stimulates trophoblast invasion: A potential mechanism for abnormal placentation in preeclampsia. J Clin Endocrinol Metab 1999;84:4092-4096.
79. Saito S, Sakakura S, Enomoto M, Ichijo M, Matsumoto K, Nakamura T: Hepatocyte growth factor promotes the growth of cytotrophoblasts by the paracrine mechanism. J Biochem (Tokyo) 1995;117:671-676.
80. Tse WK, Whitley GS, Cartwright JE: Transforming growth factor-beta1 regulates hepatocyte growth factor-induced trophoblast motility and invasion. Placenta 2002;23:699-705.
81. Cross JC, Baczyk D, Dobric N, Hemberger M, Hughes M, Simmons DG, Yamamoto H, Kingdom JC: Genes, development and evolution of the placenta. Placenta 2003;24:123-130.
82. Cartwright JE, Tse WK, Whitley GS: Hepatocyte growth factor induced human trophoblast motility involves phosphatidylinositol-3-kinase, mitogen-activated protein kinase, and inducible nitric oxide synthase. Exp Cell Res 2002;279:219-226.
83. Sawai K, Azuma C, Koyama M, Ito S, Hashimoto K, Kimura T, Samejima Y, Nobunaga T, Saji F: Leukemia inhibitory factor (LIF) enhances trophoblast differentiation mediated by human chorionic gonadotropin (hCG). Biochem Biophys Res Commun 1995;211:137-143.
84. Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, Knofler M: Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab 2004;89:812-822.
85. Knofler M, Mosl B, Bauer S, Griesinger G, Husslein P: TNF-alpha/TNFRI in primary and immortalized first trimester cytotrophoblasts. Placenta 2000;21:525-535.
86. Monzon-Bordonaba F, Vadillo-Ortega F, Feinberg RF: Modulation of trophoblast function by tumor necrosis factor-alpha: A role in pregnancy establishment and maintenance? Am J Obstet Gynecol 2002;187:1574-1580.
87. Kniss DA, Rovin B, Fertel RH, Zimmerman PD: Blockade NF-kappaB activation prohibits TNF-alpha-induced cyclooxygenase-2 gene expression in ED27 trophoblast-like cells. Placenta 2001;22:80-89.
88. Schulz LC, Widmaier EP: The effect of leptin on mouse trophoblast cell invasion. Biol Reprod 2004;71:1963-1967.
89. Gonzalez RR, Devoto L, Campana A, Bischof P: Effects of leptin, interleukin-1 alpha, interleukin-6, and transforming growth factor-beta on markers of trophoblast invasive phenotype: Integrins and metalloproteinases. Endocrine 2001;15:157-164.
90. Bifulco G, Trencia A, Caruso M, Tommaselli GA, Miele C, di Carlo C, Beguinot F, Nappi C: Leptin induces mitogenic effect on human choriocarcinoma cell line (JAr) via MAP kinase activation in a glucose-dependent fashion. Placenta 2003;24:385-391.
91. Matsuoka T, Tahara M, Yokoi T, Masumoto N, Takeda T, Yamaguchi M, Tasaka K, Kurachi H, Murata Y: Tyrosine phosphorylation of STAT3 by leptin through leptin receptor in mouse metaphase 2 stage oocyte. Biochem Biophys Res Commun 1999;256:480-484.
92. Roth I, Fisher SJ: IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev Biol 1999;205:194-204.
93. Aoki Y, Adachi S, Yoshiya N, Honma S, Kanazawa K, Tanaka K: Effects of various growth factors on the proliferation and the differentiation of trophoblastic cells in vitro. Nippon Sanka Fujinka Gakkai Zasshi 1991;43:1527-1532.
94. Friederichs K, Schmitz J, Weissenbach M, Heinrich PC, Schaper F: Interleukin-6-induced proliferation of pre-B cells mediated by receptor complexes lacking the SHP2/SOCS3 recruitment sites revisited. Eur J Biochem 2001;268:6401-6407.
95. Librach CL, Feigenbaum SL, Bass KE, Cui TY, Verastas N, Sadovsky Y, Quigley JP, French DL, Fisher SJ: Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem 1994;269:17125-17131.
96. Lewis MP, Sullivan MH, Elder MG: Regulation by interleukin-1 beta of growth and collagenase production by choriocarcinoma cells. Placenta 1994;15:13-20.
97. Haimovici F, Hill JA, Anderson DJ: The effects of soluble products of activated lymphocytes and macrophages on blastocyst implantation events in vitro. Biol Reprod 1991;44:69-75.
98. Yagel S, Lala PK, Powell WA, Casper RF: Interleukin-1 stimulates human chorionic gonadotropin secretion by first trimester human trophoblast. J Clin Endocrinol Metab 1989;68:992-995.
99. Strakova Z, Srisuparp S, Fazleabas AT: IL-1beta during in vitro decidualization in primate. J Reprod Immunol 2002;55:35-47.